TMFFishBiz’s Activity

Wed Mar 8

NL

Article

TMFFishBiz published an article 9:24 AM

1 Huge Reason to Buy Illumina, Inc. Stock Now

Illumina stands poised to move past the woes of last year with its new sequencing technology.

NL

Article

TMFFishBiz published an article 8:04 AM

Forget the Distractions: Bristol-Myers Squibb Is a Bargain

Growth opportunities for Bristol-Myers Squibb make this drug stock a bargain.

Tue Mar 7

NL

Article

TMFFishBiz published an article 4:22 PM

5 Things Biogen's CEO Just Said That You Don't Want to Miss

Biogen CEO Michel Vounatsos talks about the biotech's future at the Cowen healthcare conference.

NL

Article

TMFFishBiz published an article 8:21 AM

What Illumina's and Bristol-Myers Squibb's Latest GRAIL Moves Mean for Investors

Bristol-Myers Squibb invests in GRAIL, while Illumina's stake decreases. Do these moves help investors?

NL

Article

TMFFishBiz published an article 8:04 AM

Here's Why the Best Is Yet to Come for Gilead Sciences, Inc.

Gilead Sciences can return to and even exceed its glory days by doing three things.

NL

Article

TMFFishBiz published an article 7:04 AM

Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis

Both Regeneron and Novartis have run into hurdles recently. Which is the better stock now?

Mon Mar 6

Rule Breakers article.

TMFFishBiz published an update. 10:54 AM

Sun Mar 5

NL

Article

TMFFishBiz published an article 2:03 PM

3 Stocks to Buy As Obamacare Collapses

Why HealthEquity, UnitedHealth Group, and (surprisingly) Molina Healthcare could thrive in a post-Obamacare world.

NL

Article

TMFFishBiz published an article 11:04 AM

How Big Will the Trump Slump Be for Marijuana Stocks?

The Trump administration hints at a crackdown on states that have legalized recreational marijuana use. How bad might this be for marijuana stocks?

NL

Article

TMFFishBiz published an article 8:21 AM

5 Dividend Stocks to Buy in March

Spring ahead in March with great dividend stocks AbbVie, BP, Eversource Energy, Ford, and Welltower.

NL

Article

TMFFishBiz published an article 7:22 AM

Billionaires Love These 3 Healthcare Stocks

Billionaire investors are pouring more money into healthcare stocks -- especially Allergan, Johnson & Johnson, and Cardinal Health.

Sat Mar 4

NL

Article

TMFFishBiz published an article 12:02 PM

3 Charts That Show the Potential Risks and Rewards for Immunogen, Inc. Stock

Immunogen has a promising pipeline -- but realizing its potential is still a long way off.

NL

Article

TMFFishBiz published an article 6:42 AM

Bad News Biotechs: What's Next for Juno and PTC Therapeutics?

Can Juno and PTC Therapeutics pick up the pieces after major pipeline setbacks?

Thu Mar 2

NL

Article

TMFFishBiz published an article 9:22 AM

5 Small-Cap Biotech Stocks to Buy in March

Why small-cap biotech stocks Coherus BioSciences, Halozyme Therapeutics, PTC Therapeutics, Radius Health, and Spark Therapeutics could soar.

NL

Article

TMFFishBiz published an article 9:03 AM

78% of Americans Support This Revolutionary Healthcare Technology, but Only 21% Have Tried It

A lot of people like the idea of virtual healthcare. But few have actually tried it.

Wed Mar 1

NL

Article

TMFFishBiz published an article 6:03 PM

Juno Therapeutics' Q4 Financial Results Overshadowed by Pipeline Setback

The clinical-stage biotech reported higher quarterly revenue thanks to its collaboration with Celgene. But its move to halt development of its lead drug candidate was the bigger story.

NL

Article

TMFFishBiz published an article 4:41 PM

Better Buy: Johnson & Johnson vs. AbbVie

How Johnson & Johnson and AbbVie stack up in a head-to-head match-up of big drug stocks.

NL

Article

TMFFishBiz published an article 10:24 AM

Mylan N.V. Q4 Earnings Soar Thanks to Meda Acquisition

The drugmaker posts gains in all geographic regions in the fourth quarter after acquisition of Swedish pharmaceutical company Meda.

Stock Advisor article.

TMFFishBiz published an update. 10:10 AM

NL

Article

TMFFishBiz published an article 8:21 AM

5 Things Valeant's Management Said That You Probably Wish It Hadn't

There was plenty of bad news from Valeant Pharmaceuticals executives in the Q4 earnings call.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 74621
Score 0.00
Score Change Today +9.87
Accuracy 0.00%
Active Picks 2
Total Picks 19
Best Pick QCOR.DL (+221.68)
Worst Pick AMRN (-107.70)
Average Score per Pick -6.83
Charms Earned 2
Highest Rated Favorite No Favorites Selected
Go to TMFFishBiz’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFFishBiz’s 10 Latest Posts